Have your own idea? Try our Stock Screener
In the last week, the Biotech industry is up 2.5%, with Akeso up 7.0%. In contrast, the industry has lost 26% in the last 12 months. Earnings are forecast to grow by 39% annually.
Has the Hong Kong Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 02 Sep 2024 | HK$340.4b | HK$52.6b | -HK$19,600,279,846.78 | 11.6x | -17.4x | 6.5x |
Wed, 31 Jul 2024 | HK$308.4b | HK$49.7b | -HK$19,491,678,475.65 | 11.3x | -15.8x | 6.2x |
Fri, 28 Jun 2024 | HK$333.2b | HK$49.6b | -HK$19,437,291,027.98 | 12.1x | -17.1x | 6.7x |
Sun, 26 May 2024 | HK$344.5b | HK$49.8b | -HK$19,517,236,241.02 | 11.7x | -17.7x | 6.9x |
Tue, 23 Apr 2024 | HK$315.9b | HK$49.5b | -HK$19,910,409,871.62 | 10.8x | -15.9x | 6.4x |
Thu, 21 Mar 2024 | HK$363.4b | HK$47.8b | -HK$20,968,633,010.96 | 17.5x | -17.3x | 7.6x |
Sat, 17 Feb 2024 | HK$337.6b | HK$47.2b | -HK$20,382,504,617.35 | 16.3x | -16.6x | 7.2x |
Mon, 15 Jan 2024 | HK$381.0b | HK$46.9b | -HK$20,252,418,110.00 | 17.7x | -18.8x | 8.1x |
Wed, 13 Dec 2023 | HK$401.1b | HK$46.8b | -HK$20,200,802,361.00 | 17.9x | -19.9x | 8.6x |
Fri, 10 Nov 2023 | HK$421.8b | HK$45.2b | -HK$18,930,524,594.00 | 13.5x | -22.3x | 9.3x |
Sun, 08 Oct 2023 | HK$388.5b | HK$45.0b | -HK$19,137,116,705.00 | 13.8x | -20.3x | 8.6x |
Tue, 05 Sep 2023 | HK$412.3b | HK$45.1b | -HK$16,929,241,645.00 | 15.1x | -24.4x | 9.1x |
Thu, 03 Aug 2023 | HK$397.0b | HK$35.5b | -HK$23,337,130,199.00 | 22x | -17x | 11.2x |
Sat, 01 Jul 2023 | HK$391.5b | HK$35.2b | -HK$23,144,115,321.00 | 25.3x | -16.9x | 11.1x |
Mon, 29 May 2023 | HK$418.5b | HK$36.0b | -HK$23,771,398,625.00 | 29.5x | -17.6x | 11.6x |
Wed, 26 Apr 2023 | HK$437.1b | HK$36.8b | -HK$24,032,083,790.00 | 18.6x | -18.2x | 11.9x |
Fri, 24 Mar 2023 | HK$429.7b | HK$35.0b | -HK$36,661,632,123.00 | 22.5x | -11.7x | 12.3x |
Sun, 19 Feb 2023 | HK$415.4b | HK$34.6b | -HK$34,907,192,228.00 | 32.6x | -11.9x | 12x |
Tue, 17 Jan 2023 | HK$468.0b | HK$35.0b | -HK$35,421,330,962.00 | 32.6x | -13.2x | 13.4x |
Thu, 15 Dec 2022 | HK$402.8b | HK$33.6b | -HK$33,929,185,420.00 | 25.7x | -11.9x | 12x |
Sat, 12 Nov 2022 | HK$351.8b | HK$33.7b | -HK$32,367,923,461.00 | 17.3x | -10.9x | 10.5x |
Mon, 10 Oct 2022 | HK$296.0b | HK$34.0b | -HK$32,532,101,794.00 | 16.4x | -9.1x | 8.7x |
Wed, 07 Sep 2022 | HK$320.5b | HK$34.4b | -HK$33,730,074,655.00 | 16.5x | -9.5x | 9.3x |
Fri, 05 Aug 2022 | HK$321.0b | HK$32.8b | -HK$46,309,057,875.00 | 12.1x | -6.9x | 9.8x |
Sun, 03 Jul 2022 | HK$368.6b | HK$33.1b | -HK$46,627,164,079.00 | 15.1x | -7.9x | 11.1x |
Tue, 31 May 2022 | HK$321.7b | HK$34.1b | -HK$45,954,938,846.00 | 13x | -7x | 9.4x |
Thu, 28 Apr 2022 | HK$319.9b | HK$35.6b | -HK$45,008,839,288.00 | 12.8x | -7.1x | 9x |
Sat, 26 Mar 2022 | HK$334.0b | HK$36.1b | -HK$38,675,782,158.00 | 13.4x | -8.6x | 9.3x |
Mon, 21 Feb 2022 | HK$315.1b | HK$31.3b | -HK$32,034,553,209.00 | 12.4x | -9.8x | 10.1x |
Wed, 19 Jan 2022 | HK$381.4b | HK$31.1b | -HK$31,891,209,285.00 | 13.2x | -12x | 12.2x |
Fri, 17 Dec 2021 | HK$442.9b | HK$31.1b | -HK$31,844,824,921.00 | 13.4x | -13.9x | 14.2x |
Sun, 14 Nov 2021 | HK$489.1b | HK$31.0b | -HK$31,744,501,684.00 | 14.4x | -15.4x | 15.8x |
Tue, 12 Oct 2021 | HK$498.7b | HK$30.5b | -HK$31,547,002,088.00 | 14.8x | -15.8x | 16.3x |
Thu, 09 Sep 2021 | HK$520.3b | HK$30.4b | -HK$31,412,511,864.39 | 17.5x | -16.6x | 17.1x |
-16.6x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 1.07% | |
Healthcare | 4.37% | |
Biotech | 2.54% | |
Biotech | 2.54% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
9926 Akeso | HK$50.30 | 7.7% +HK$3.1b | 42.9% | PS21.2x | |
2162 Keymed Biosciences | HK$35.50 | 11.1% +HK$981.9m | -31.8% | PS109.6x | |
1952 Everest Medicines | HK$21.85 | 9.0% +HK$577.5m | 17.6% | PS15.3x | |
6855 Ascentage Pharma Group International | HK$33.95 | 4.8% +HK$479.2m | 44.5% | PS10.6x | |
6826 Shanghai Haohai Biological Technology | HK$31.65 | 6.2% +HK$426.3m | -5.8% | PE15x |